LCGC
EXAS

Legacy Capital Group California’s Exact Sciences EXAS Stock Holding History

Legacy Capital Group California’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,852
Closed -$1.01M – 283
2023
Q3 		$1.01M Buy
14,852
+145
+1% +$12.3K 0.44% 54
2023
Q2 		$1.38M Buy
+14,707
New +$1.15M 0.57% 29

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Legacy Capital Group California's EXAS Position: Q4 2023 in Review

Legacy Capital Group California sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 14,852 shares — an estimated $1.01M sold.

Legacy Capital Group California first reported a position in EXAS in Q2 2023 and held it in 2 quarters. The position peaked at $1.38M in Q2 2023. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Legacy Capital Group California reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Legacy Capital Group California sold 14,852 Exact Sciences shares in Q4 2023, an estimated $1.01M.
  • Legacy Capital Group California first reported a position in Exact Sciences in Q2 2023 and held it in 2 quarters.
  • Legacy Capital Group California's Exact Sciences position peaked at $1.38M in Q2 2023.
  • 648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Legacy Capital Group California's 13F filing for Q4 2023, filed 8 Feb 2024.